GO:0006574 L-valine catabolic process: Metabolic Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0006574 (L-valine catabolic process) describes the chemical reactions and pathways that break down L-valine, a branched-chain amino acid, into smaller metabolites.
• The term is a biological_process in the Gene Ontology and includes synonyms such as valine breakdown, valine catabolism, valine degradation, and valine degradation via the Ehrlich pathway.
• L-valine catabolism is central to branched-chain amino acid metabolism and is studied in bacteria, fungi, plants, and animals, with major relevance to metabolic engineering and human metabolic disease.
• Key enzymes and regulators include branched-chain aminotransferases (BCAT/IlvE), branched-chain alpha-keto acid dehydrogenases (BCKDH), and downstream acyl-CoA thioesterases and dehydrogenases.
• Dysregulation of L-valine catabolism is linked to maple syrup urine disease, branched-chain organic acidurias, and altered cancer cell metabolism.
• CRISPR knockout, point-mutation, knock-in, and overexpression models are powerful tools to dissect the causal roles of genes in L-valine catabolic process.
Description
L-valine is one of the three branched-chain amino acids (BCAAs) and is essential for protein synthesis, nitrogen balance, and energy homeostasis in many organisms. The Gene Ontology term GO:0006574, L-valine catabolic process, defines the chemical reactions and pathways resulting in the breakdown of L-valine. This process is not merely a catabolic housekeeping route; it is a hub that connects amino acid degradation to central carbon metabolism, cofactor recycling, and the production of metabolic intermediates such as propionyl-CoA and acetyl-CoA. Understanding L-valine catabolism is therefore important for both fundamental biochemistry and applied biotechnology. In bacteria such as Corynebacterium glutamicum, Escherichia coli, Klebsiella oxytoca, and Cupriavidus necator, L-valine catabolism and its reverse anabolic pathways are intensively engineered to improve L-valine production titers and yields. In these systems, the catabolic process is often studied in parallel with biosynthesis because the same enzymes and regulators can participate in both directions depending on metabolic context. In eukaryotes, L-valine catabolism is compartmentalized and tightly regulated, and its dysfunction is associated with inherited metabolic disorders and altered cancer metabolism. This article provides a research-grade overview of GO:0006574, covering its definition, mechanistic steps, key genes, regulation, disease links, experimental models, and CRISPR-based research strategies. All statements are grounded in the verified literature listed in the citation set.
L-valine catabolic process At A Glance
| GO ID | GO:0006574 |
|---|---|
| GO term | L-valine catabolic process |
| Ontology | biological_process |
| Definition | The chemical reactions and pathways resulting in the breakdown of L-valine. |
| Synonym | valine breakdown; valine catabolism; valine degradation; valine degradation via Ehrlich pathway |
| Major function | Degradation of L-valine to produce energy and metabolic intermediates such as propionyl-CoA and acetyl-CoA. |
| Related pathways | Branched-chain amino acid catabolism, propanoate metabolism, and central carbon metabolism. |
| Key enzymes | Branched-chain aminotransferase (BCAT/IlvE), branched-chain alpha-keto acid dehydrogenase (BCKDH), acyl-CoA dehydrogenases and thioesterases. |
| Organisms studied | Bacteria (Corynebacterium glutamicum, Escherichia coli, Klebsiella oxytoca, Cupriavidus necator), fungi, plants, and mammals. |
| Disease relevance | Maple syrup urine disease, branched-chain organic acidurias, and cancer metabolic reprogramming. |
What Is GO:0006574?
GO:0006574, L-valine catabolic process, is a biological_process term in the Gene Ontology that describes the chemical reactions and pathways resulting in the breakdown of L-valine. It encompasses the enzymatic steps that convert L-valine into downstream metabolites, including transamination, oxidative decarboxylation, and further oxidation or thiolytic cleavage of the resulting acyl-CoA intermediates. The term is synonymous with valine breakdown, valine catabolism, valine degradation, and valine degradation via the Ehrlich pathway. It is distinct from L-valine biosynthetic process and from the catabolism of other branched-chain amino acids, although the pathways share enzymes and regulatory logic.
Why Is L-valine catabolic process Important in Cell Biology?
L-valine catabolic process is important because it sits at the intersection of amino acid degradation, energy metabolism, and industrial biotechnology. In microorganisms, manipulating this pathway is a proven strategy to redirect carbon flux toward L-valine production or to improve host tolerance and yield. In humans, defects in branched-chain amino acid catabolism, including L-valine catabolism, cause severe metabolic disorders such as maple syrup urine disease, and altered catabolic flux is observed in cancer and metabolic syndrome. Studying GO:0006574 therefore provides mechanistic insight into both basic metabolism and translational applications.
• L-valine catabolism supplies carbon skeletons and energy through propionyl-CoA and acetyl-CoA, linking BCAA degradation to the TCA cycle.
• The pathway is a target for metabolic engineering to improve L-valine production in industrial strains.
• Enzymes such as BCAT and BCKDH are shared with isoleucine and leucine catabolism, making the pathway a model for branched-chain amino acid regulation.
• Defects in L-valine catabolism contribute to maple syrup urine disease and related organic acidurias.
• Cancer cells often reprogram branched-chain amino acid catabolism, making this pathway relevant to oncology.
• The Ehrlich pathway variant of valine degradation is important in yeast and fungi for flavor compound production.
• Understanding catabolic flux helps optimize fermentation conditions for anaerobic L-valine production.
• CRISPR-based models enable causal testing of catabolic genes in diverse organisms.
What Happens During L-valine catabolic process?
Transamination of L-valine to alpha-ketoisovalerate
In simple terms: The first step removes the amino group from valine and converts it into a related keto acid.
The catabolism of L-valine typically begins with a transamination reaction catalyzed by branched-chain aminotransferases such as BCAT in mammals or IlvE in bacteria. In this step, L-valine donates its amino group to an acceptor, usually alpha-ketoglutarate, yielding alpha-ketoisovalerate (2-ketoisovalerate) and glutamate. This reversible reaction is a key node because alpha-ketoisovalerate can also be redirected toward valine biosynthesis or other branched-chain amino acid pathways. In metabolic engineering studies, the expression and specificity of transaminases are often modulated to control flux through L-valine catabolism.
Oxidative decarboxylation by the branched-chain alpha-keto acid dehydrogenase complex
In simple terms: The keto acid is then broken down further by a large enzyme complex that removes carbon dioxide and attaches coenzyme A.
Alpha-ketoisovalerate undergoes oxidative decarboxylation catalyzed by the branched-chain alpha-keto acid dehydrogenase (BCKDH) complex, producing isobutyryl-CoA. This irreversible step commits the carbon skeleton to catabolism and is a major regulatory point in branched-chain amino acid degradation. BCKDH is a multienzyme complex that requires thiamine pyrophosphate, lipoic acid, CoA, FAD, and NAD+ as cofactors. In bacteria, the equivalent enzyme system (often encoded by bkd genes) performs the same reaction and is important for valine catabolism during fermentation.
Dehydrogenation and hydration of isobutyryl-CoA
In simple terms: The CoA-bound intermediate is further oxidized and modified to prepare for cleavage.
Isobutyryl-CoA is dehydrogenated by acyl-CoA dehydrogenases to methacrylyl-CoA, which is then hydrated to 3-hydroxyisobutyryl-CoA. These reactions introduce oxygen functionality and prepare the molecule for subsequent oxidation and cleavage steps. In some organisms, alternative enzymes such as isobutyryl-CoA mutase or specific dehydratases may participate, reflecting pathway diversity. The flux through these steps can influence the accumulation of toxic intermediates, which is relevant to inherited metabolic disorders.
Oxidation to methylmalonate semialdehyde and propionyl-CoA formation
In simple terms: The molecule is converted into a semialdehyde and then into propionyl-CoA, a central metabolic intermediate.
3-Hydroxyisobutyryl-CoA is oxidized to methylmalonate semialdehyde, which can be further oxidized to propionyl-CoA. Propionyl-CoA is a key metabolite that enters the TCA cycle after carboxylation to methylmalonyl-CoA and isomerization to succinyl-CoA. This step links L-valine catabolism to propanoate metabolism and to gluconeogenesis in some tissues. In engineered microorganisms, redirecting propionyl-CoA flux is a strategy to balance redox and energy metabolism during L-valine production.
The Ehrlich pathway variant in yeast and fungi
In simple terms: In yeast, valine can be broken down into fusel alcohols and acids through a specialized route.
The Ehrlich pathway is a fungal catabolic route in which L-valine is transaminated to alpha-ketoisovalerate, decarboxylated to isobutyraldehyde, and then reduced or oxidized to isobutanol or isobutyric acid. This pathway is a synonym for valine degradation via the Ehrlich pathway and is important for flavor and aroma compound production in fermented foods and beverages. The Ehrlich pathway shares the initial transamination step with the canonical BCAA catabolic pathway but diverges at the decarboxylation step. Metabolic engineers have exploited this pathway for production of higher alcohols and chemicals from valine.
Key Genes Involved in GO:0006574 L-valine catabolic process
The following genes and proteins are central to L-valine catabolic process across model organisms and industrial strains.
| Gene | Major Role | Research Relevance |
|---|---|---|
| BCAT1 | Branched-chain aminotransferase; transaminates L-valine to alpha-ketoisovalerate | Target for cancer metabolism and metabolic engineering studies |
| BCAT2 | Mitochondrial branched-chain aminotransferase; initiates BCAA catabolism | Model for inherited metabolic disorders and mitochondrial metabolism |
| BCKDHA | E1 alpha subunit of BCKDH complex; oxidative decarboxylation of alpha-keto acids | Mutations cause maple syrup urine disease; CRISPR models available |
| BCKDHB | E1 beta subunit of BCKDH complex | Disease modeling and structural studies |
| DBT | Dihydrolipoamide branched-chain transacylase; BCKDH complex component | Maple syrup urine disease and metabolic flux studies |
| DLD | Dihydrolipoamide dehydrogenase; reoxidizes lipoamide in BCKDH | Links BCAA catabolism to redox metabolism |
| ILV E (ilvE) | Bacterial branched-chain aminotransferase | Key target for L-valine production in C. glutamicum and E. coli |
| bkdA | Bacterial BCKDH E1 alpha subunit | Metabolic engineering of valine catabolism |
| bkdB | Bacterial BCKDH E1 beta subunit | Flux control in fermentation |
| lpd | Bacterial dihydrolipoamide dehydrogenase | Redox balance during valine catabolism |
| ACAD8 | Isobutyryl-CoA dehydrogenase | Inborn errors of valine catabolism |
| HIBCH | 3-Hydroxyisobutyryl-CoA hydrolase | Neurodegenerative metabolic disease models |
| ALDH6A1 | Methylmalonate semialdehyde dehydrogenase | Propionyl-CoA flux and organic aciduria |
| PCCA | Propionyl-CoA carboxylase alpha subunit | Links valine catabolism to propanoate metabolism |
| PCCB | Propionyl-CoA carboxylase beta subunit | Propionic acidemia models |
| MUT | Methylmalonyl-CoA mutase | Succinyl-CoA formation from valine-derived propionyl-CoA |
| ADH1 (yeast) | Alcohol dehydrogenase in Ehrlich pathway | Fusel alcohol production and yeast metabolism |
| PDC1 (yeast) | Pyruvate decarboxylase; decarboxylates alpha-keto acids in Ehrlich pathway | Flavor compound engineering |
How Is L-valine catabolic process Regulated?
L-valine catabolic process is regulated at multiple levels, including transcriptional control, enzyme phosphorylation, and allosteric feedback. The BCKDH complex is inhibited by phosphorylation by BCKDH kinase and activated by BCKDH phosphatase, providing rapid control of branched-chain amino acid catabolism. In bacteria, expression of catabolic genes is often controlled by global regulators of nitrogen and carbon metabolism, and flux is influenced by oxygen availability and redox state. In metabolic engineering studies, promoters and ribosome binding sites are tuned to balance catabolic and anabolic flux for optimal L-valine production. In yeast, the Ehrlich pathway is regulated by nitrogen catabolite repression and amino acid availability.
L-valine catabolic process and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| BCKDHA | Maple syrup urine disease | CRISPR knockout in hepatocytes or induced pluripotent stem cells |
| BCKDHB | Maple syrup urine disease | Point-mutation knock-in in cell lines |
| DBT | Maple syrup urine disease | Knockout and rescue with wild-type or mutant DBT |
| HIBCH | HIBCH deficiency with neurodegeneration | Neuronal knockout models and metabolite toxicity assays |
| ALDH6A1 | Methylmalonate semialdehyde dehydrogenase deficiency | Knockout in fibroblasts and metabolomics |
Maple syrup urine disease and branched-chain organic acidurias
Deficiency of the branched-chain alpha-keto acid dehydrogenase complex, which catalyzes the second step of L-valine catabolism, causes maple syrup urine disease, characterized by accumulation of branched-chain amino acids and their keto acids. Mutations in BCKDHA, BCKDHB, DBT, or DLD underlie different forms of the disease, and CRISPR knockout models in cell lines and animal models are used to study pathophysiology. Downstream enzyme deficiencies such as ACAD8, HIBCH, and ALDH6A1 defects also impair valine catabolism and cause organic acidurias with neurological symptoms.
Cancer metabolism and branched-chain amino acid catabolism
Altered branched-chain amino acid catabolism, including L-valine catabolism, has been observed in several cancers, where it can support energy production and biosynthetic needs. BCAT1 and BCAT2 expression is dysregulated in some tumors, and targeting these enzymes is being explored as a therapeutic strategy. CRISPR knockout and point-mutation models are valuable for testing the causal role of catabolic genes in cancer cell proliferation and survival.
Neurodegeneration and metabolic stress
Impaired valine catabolism can lead to accumulation of neurotoxic metabolites such as methacrylyl-CoA and 3-hydroxyisobutyrate, which have been linked to neurodegeneration in inherited metabolic disorders. HIBCH and ALDH6A1 deficiencies are associated with neurological regression and Leigh-like syndromes. Studying these pathways in neuronal cell models using CRISPR-based gene editing can help dissect mechanisms of metabolite toxicity.
From L-valine catabolic process-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of BCAT1 alter L-valine catabolic flux? | CRISPR knockout in cancer cell lines followed by metabolomics |
| Does a specific BCKDHA mutation cause maple syrup urine disease phenotypes? | Point-mutation knock-in in patient-derived cells |
| Can restoring BCKDH activity rescue catabolic defects? | Knock-in of wild-type BCKDHA in mutant cells |
| What is the role of HIBCH in neuronal survival? | CRISPR knockout in neuronal progenitor cells |
| Can overexpression of catabolic genes increase L-valine production? | Overexpression in C. glutamicum or E. coli |
| How does the Ehrlich pathway affect flavor compound production? | Overexpression or knockout in yeast |
How to Study the L-valine catabolic process Process
| Method | What It Measures | Typical Application |
|---|---|---|
| LC-MS metabolomics | Levels of valine and catabolic intermediates | Flux analysis in CRISPR models |
| 13C-valine tracing | Flux through catabolic pathway | Metabolic engineering and cancer metabolism |
| BCAT activity assay | Transamination rate | Functional validation of gene edits |
| BCKDH activity assay | Oxidative decarboxylation rate | Diagnosis of maple syrup urine disease |
| RNA-seq | Transcriptional changes | Regulatory network analysis |
| Proteomics | Protein abundance and modifications | Pathway regulation studies |
| CRISPR knockout screen | Gene essentiality and fitness | Discovery of catabolic regulators |
| CRISPR activation screen | Gain-of-function phenotypes | Identification of rate-limiting steps |
Metabolomics and flux analysis
Metabolomics using LC-MS or GC-MS can quantify L-valine and its catabolic intermediates such as alpha-ketoisovalerate, isobutyryl-CoA, and propionyl-CoA. Stable isotope tracing with 13C-labeled valine enables flux analysis through the pathway. These methods are essential for validating CRISPR models and for metabolic engineering studies.
Enzyme activity assays
Branched-chain aminotransferase and BCKDH activities can be measured in cell lysates or purified preparations using spectrophotometric or radiometric assays. These assays help determine the functional impact of point mutations or knockouts. For bacterial systems, enzyme activities are often coupled to growth or production phenotypes.
Transcriptomics and proteomics
RNA-seq and quantitative proteomics can reveal changes in expression of catabolic genes under different conditions or in CRISPR models. These approaches help identify regulatory networks and compensatory pathways. In metabolic engineering, omics data guide the design of strains with optimized catabolic flux.
CRISPR screening and functional genomics
Genome-wide CRISPR knockout or activation screens can identify genes that modulate L-valine catabolism or sensitivity to valine restriction. Such screens are powerful for discovering novel regulators and for identifying therapeutic targets in cancer metabolism. Bioinformatics analysis of screening data is critical for hit prioritization.
How CRISPR Can Be Used to Study GO:0006574 L-valine catabolic process
Knockout
CRISPR knockout of genes such as BCAT1, BCAT2, BCKDHA, or HIBCH can abolish specific steps in L-valine catabolism, allowing researchers to determine their contribution to flux and phenotype. Knockout models are widely used in cancer metabolism and inherited metabolic disease research. In industrial microorganisms, knockout of competing catabolic pathways can redirect carbon toward L-valine production.
Point Mutation
Point mutations identified in patients with maple syrup urine disease or organic acidurias can be introduced into cell lines using CRISPR base editing or homology-directed repair to model disease-specific effects. Such models help distinguish loss-of-function from dominant-negative or gain-of-function mechanisms. They are also useful for testing pharmacological chaperones or substrate analogs.
Knock-in
Knock-in of wild-type or tagged catabolic genes enables rescue experiments and protein localization studies. For example, knocking in a tagged BCKDHA can reveal its mitochondrial import and assembly into the BCKDH complex. Knock-in models are also used to express heterologous catabolic enzymes in industrial strains for pathway engineering.
Overexpression
Overexpression of catabolic genes such as ilvE, bkdA, or bkdB can increase flux through L-valine catabolism or, in reverse, enhance production when combined with anabolic engineering. In yeast, overexpression of Ehrlich pathway genes increases fusel alcohol production. CRISPR activation (CRISPRa) provides a tunable way to overexpress endogenous genes without transgene integration.
How EDITGENE Supports L-valine catabolic process Research
Researchers studying L-valine catabolic process-related genes often need to determine whether a candidate gene is causally involved in pathway flux, disease phenotypes, or metabolic engineering outcomes. EDITGENE provides end-to-end CRISPR services to generate precisely engineered cell models for such studies.
Contact EDITGENE today to design your custom CRISPR model for L-valine catabolic process research.
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| BCKDK Knockout HEK293 Cell Line | EDJ-KQ1127 | Human | 10295 | Details Get a Quote |
| HIBADH Knockout HEK293 Cell Line | EDJ-KQ2273 | Human | 11112 | Details Get a Quote |
| BCAT1 Knockout HEK293 Cell Line | EDJ-KQ3038 | Human | 586 | Details Get a Quote |
| BCAT2 Knockout HEK293 Cell Line | EDJ-KQ4126 | Human | 587 | Details Get a Quote |
| BCKDHB Knockout HEK293 Cell Line | EDJ-KQ4129 | Human | 594 | Details Get a Quote |
| DBT Knockout HEK293 Cell Line | EDJ-KQ4430 | Human | 1629 | Details Get a Quote |
| ECHS1 Knockout HEK293 Cell Line | EDJ-KQ4495 | Human | 1892 | Details Get a Quote |
| ALDH6A1 Knockout HEK293 Cell Line | EDJ-KQ5224 | Human | 4329 | Details Get a Quote |
| HIBCH Knockout HEK293 Cell Line | EDJ-KQ8497 | Human | 26275 | Details Get a Quote |
| ACAD8 Knockout HEK293 Cell Line | EDJ-KQ8651 | Human | 27034 | Details Get a Quote |
| BCKDK Knockout HCT 116 Cell Line | EDJ-KQ18979 | Human | 10295 | Details Get a Quote |
| DBT Knockout A-549 Cell Line | EDJ-KQ26971 | Human | 1629 | Details Get a Quote |
| DBT Knockout HeLa Cell Line | EDJ-KQ26973 | Human | 1629 | Details Get a Quote |
| ECHS1 Knockout A-549 Cell Line | EDJ-KQ27075 | Human | 1892 | Details Get a Quote |
| ECHS1 Knockout HeLa Cell Line | EDJ-KQ27077 | Human | 1892 | Details Get a Quote |
Displaying Records 1 To 15 Of 42 Records
- 1
- 2
- Next Page »
Frequently Asked Questions About L-valine catabolic process
What is GO:0006574 L-valine catabolic process?
GO:0006574 is a Gene Ontology biological_process term defined as the chemical reactions and pathways resulting in the breakdown of L-valine.
What genes are involved in L-valine catabolic process?
Key genes include BCAT1, BCAT2, BCKDHA, BCKDHB, DBT, DLD, ACAD8, HIBCH, ALDH6A1, PCCA, PCCB, and MUT, as well as bacterial genes such as ilvE and bkdA.
What are the synonyms for L-valine catabolic process?
Synonyms include valine breakdown, valine catabolism, valine degradation, and valine degradation via the Ehrlich pathway.
Why is L-valine catabolism important in biotechnology?
It is important because manipulating this pathway can redirect carbon flux to improve L-valine production in industrial strains such as Corynebacterium glutamicum and Escherichia coli.
What diseases are linked to defects in L-valine catabolism?
Defects cause maple syrup urine disease and other branched-chain organic acidurias, and altered catabolism is observed in cancer.
How is L-valine catabolism studied experimentally?
It is studied using metabolomics, enzyme activity assays, transcriptomics, proteomics, and CRISPR-based gene editing models.
What is the Ehrlich pathway in valine degradation?
The Ehrlich pathway is a yeast and fungal route that converts L-valine to fusel alcohols and acids via transamination, decarboxylation, and reduction or oxidation.
Can CRISPR be used to study L-valine catabolic process?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models are widely used to dissect gene function in this pathway.
What is the first step of L-valine catabolism?
The first step is usually transamination of L-valine to alpha-ketoisovalerate by branched-chain aminotransferases such as BCAT or IlvE.
How does L-valine catabolism connect to energy production?
It produces propionyl-CoA and acetyl-CoA, which enter the TCA cycle and support energy production and gluconeogenesis.
Conclusion
GO:0006574 L-valine catabolic process is a fundamental biological pathway that bridges amino acid degradation, energy metabolism, and industrial biotechnology. Its enzymes and regulators are implicated in inherited metabolic diseases and cancer, and they are prime targets for metabolic engineering. CRISPR-based models provide powerful tools to establish causal relationships between specific genes and pathway function. Researchers can leverage EDITGENE services to accelerate discovery in this field.
References
- 1. Liu J et al.. 2021. L-valine production in Corynebacterium glutamicum based on systematic metabolic engineering: progress and prospects.. Amino Acids 53(9):1301-1312 PMID: 34401958
- 2. Cao M et al.. 2024. Efficient L-valine production using systematically metabolic engineered Klebsiella oxytoca.. Bioresour Technol 395:130403 PMID: 38295958
- 3. Wang X et al.. 2018. Production of L-valine from metabolically engineered Corynebacterium glutamicum.. Appl Microbiol Biotechnol 102(10):4319-4330 PMID: 29594358
- 4. Hao Y et al.. 2022. High-level production of L-valine in Escherichia coli using multi-modular engineering.. Bioresour Technol 359:127461 PMID: 35700900
- 5. Wang L et al.. 2024. Heterotrophic and autotrophic production of L-isoleucine and L-valine by engineered Cupriavidus necator H16.. Bioresour Technol 398:130538 PMID: 38452952
- 6. Oldiges M et al.. 2014. Application of metabolic engineering for the biotechnological production of L-valine.. Appl Microbiol Biotechnol 98(13):5859-70 PMID: 24816722
- 7. Yu H et al.. 2025. [Metabolic engineering of Corynebacterium glutamicum for L-valine production].. Sheng Wu Gong Cheng Xue Bao 41(9):3504-3520 PMID: 40994331
- 8. Yang S et al.. 2026. Anaerobic metabolic evolution for homotypic L-valine fermentation.. Nat Commun 17(1) PMID: 42215457
